1292016

Lelypharma BV — FEI 3015660451

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lelystad (Netherlands)